This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Hereditary Breast Cancer

HENRY T. LYNCH, MD

Arch Surg. 1990;125(2):151-152.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The most sorely neglected portion of a patient's medical evaluation pertains to the family history of cancer of any type, including breast cancer. This is paradoxical—no one is at greater risk for breast cancer than a woman whose mother or sister had breast cancer (or another integrally associated hereditary syndrome cancer) and who is in the direct genetic lineage of a relative with hereditary breast cancer (HBC). The lifetime breast cancer risk for such a patient is 50%! Recognition of HBC, particularly when targeted surveillance/management programs are enforced for such high-risk patients, could be one of the most powerful and potentially cost-effective models for cancer control. Research on patients with HBC holds promise for the elucidation of etiology, biomolecular markers of the cancer-susceptible genotype, and carcinogenesis. However, success in all of these ventures will necessarily be contingent on the meticulous compilation of the family history.

This commentary on HBC in . . . [Full Text PDF of this Article]

Author Affiliations
Omaha, Neb

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?